A citation-based method for searching scientific literature

M Liotti, L O Ramig, D Vogel, P New, C I Cook, R J Ingham, J C Ingham, P T Fox. Neurology 2003
Times Cited: 115







List of co-cited articles
814 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis.
Shalini Narayana, Peter T Fox, Wei Zhang, Crystal Franklin, Donald A Robin, Deanie Vogel, Lorraine O Ramig. Hum Brain Mapp 2010
59
64

Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
L O Ramig, S Sapir, S Countryman, A A Pawlas, C O'Brien, M Hoehn, L L Thompson. J Neurol Neurosurg Psychiatry 2001
247
37

Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
Serge Pinto, Stéphane Thobois, Nicolas Costes, Didier Le Bars, Alim-Louis Benabid, Emmanuel Broussolle, Pierre Pollak, Michèle Gentil. Brain 2004
71
43

Treatments for dysarthria in Parkinson's disease.
Serge Pinto, Canan Ozsancak, Elina Tripoliti, Stéphane Thobois, Patricia Limousin-Dowsey, Pascal Auzou. Lancet Neurol 2004
140
30


Comparison of two forms of intensive speech treatment for Parkinson disease.
L O Ramig, S Countryman, L L Thompson, Y Horii. J Speech Hear Res 1995
220
28

Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients.
J A Logemann, H B Fisher, B Boshes, E R Blonsky. J Speech Hear Disord 1978
328
23

Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
A El Sharkawi, L Ramig, J A Logemann, B R Pauloski, A W Rademaker, C H Smith, A Pawlas, S Baum, C Werner. J Neurol Neurosurg Psychiatry 2002
131
20


Pathomechanisms and compensatory efforts related to Parkinsonian speech.
Christiane Arnold, Johannes Gehrig, Suzana Gispert, Carola Seifried, Christian A Kell. Neuroimage Clin 2013
50
40

Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
19

Intensive voice treatment in Parkinson disease: laryngostroboscopic findings.
M E Smith, L O Ramig, C Dromey, K S Perez, R Samandari. J Voice 1995
109
19




Clusters of deviant speech dimensions in the dysarthrias.
F L Darley, A E Aronson, J R Brown. J Speech Hear Res 1969
397
17

Speech impairment in a large sample of patients with Parkinson's disease.
A K Ho, R Iansek, C Marigliani, J L Bradshaw, S Gates. Behav Neurol 1999
155
17

Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease.
Irena Rektorova, Jennifer Barrett, Michal Mikl, Ivan Rektor, Tomas Paus. Mov Disord 2007
30
56

Differential diagnostic patterns of dysarthria.
F L Darley, A E Aronson, J R Brown. J Speech Hear Res 1969
620
16



Life with communication changes in Parkinson's disease.
Nick Miller, Emma Noble, Diana Jones, David Burn. Age Ageing 2006
159
16


The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data.
Jennifer L Spielman, Joan C Borod, Lorraine O Ramig. Cogn Behav Neurol 2003
28
53

Volume perception in parkinsonian speech.
A K Ho, J L Bradshaw, T Iansek. Mov Disord 2000
61
24




A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease.
Shalini Narayana, Adam Jacks, Donald A Robin, Howard Poizner, Wei Zhang, Crystal Franklin, Mario Liotti, Deanie Vogel, Peter T Fox. Am J Speech Lang Pathol 2009
36
36

Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging.
K K Baker, L O Ramig, E S Luschei, M E Smith. Neurology 1998
83
14

The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
Cynthia M Fox, Lorraine O Ramig, Michelle R Ciucci, Shimon Sapir, David H McFarland, Becky G Farley. Semin Speech Lang 2006
111
12


Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
11

Articulatory deficits in parkinsonian dysarthria: an acoustic analysis.
H Ackermann, W Ziegler. J Neurol Neurosurg Psychiatry 1991
118
11

Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech.
Serge Pinto, Michèle Gentil, Paul Krack, Paul Sauleau, Valérie Fraix, Alim-Louis Benabid, Pierre Pollak. Mov Disord 2005
54
20

Speech breathing in Parkinson's disease.
N P Solomon, T J Hixon. J Speech Hear Res 1993
125
11

Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.
Shimon Sapir, Lorraine O Ramig, Patricia Hoyt, Stefanie Countryman, Christopher O'Brien, Margaret Hoehn. Folia Phoniatr Logop 2002
61
18

Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation.
Elina Tripoliti, Ludvic Zrinzo, Irene Martinez-Torres, Stephen Tisch, Eleanor Frost, Ellie Borrell, Marwan I Hariz, Patricia Limousin. Mov Disord 2008
102
11

Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech.
Shimon Sapir, Lorraine O Ramig, Jennifer L Spielman, Cynthia Fox. J Speech Lang Hear Res 2010
108
11

Functional neuroanatomy of vocalization in patients with Parkinson's disease.
I Rektorova, M Mikl, J Barrett, R Marecek, I Rektor, T Paus. J Neurol Sci 2012
27
40


Pathophysiology of bradykinesia in Parkinson's disease.
A Berardelli, J C Rothwell, P D Thompson, M Hallett. Brain 2001
469
10

Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa.
B Haslinger, P Erhard, N Kämpfe, H Boecker, E Rummeny, M Schwaiger, B Conrad, A O Ceballos-Baumann. Brain 2001
358
10


For better or worse: The effect of levodopa on speech in Parkinson's disease.
Aileen K Ho, John L Bradshaw, Robert Iansek. Mov Disord 2008
88
11

Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment.
Shimon Sapir, Lorraine O Ramig, Cynthia M Fox. Expert Rev Neurother 2011
51
19

Sensorimotor adaptation of speech in Parkinson's disease.
Fatemeh Mollaei, Douglas M Shiller, Vincent L Gracco. Mov Disord 2013
56
17

Speech therapy and Parkinson's disease: a review and further data.
J A Johnson, T R Pring. Br J Disord Commun 1990
57
15

Speech treatment for Parkinson's disease.
Marilyn Trail, Cynthia Fox, Lorraine Olson Ramig, Shimon Sapir, Julia Howard, Eugene C Lai. NeuroRehabilitation 2005
43
20

Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
Kris Tjaden, Gregory E Wilding. J Speech Lang Hear Res 2004
164
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.